Additionally, nebivolol has been shown to improve insulin resistance related variables, fasting glucose, fasting insulin, and the homeostatic model assessment of insulin resistance (HOMA-IR) (Metwally et al., 2020). This evidence concerns the gene INS and Insulin resistance.